Shire in Licensing Agreement with Santaris for Development of RNA-based Medicines

WALTHAM, MA — Shire, a worldwide leading specialty biopharmaceutical company, has entered into a collaboration and licensing agreement with Santaris Pharma A/S to develop RNA-based medicines for the treatment of rare genetic disorders.

Morse, Barnes-Brown & Pendleton serves as counsel to Shire and advised it in connection with the structuring, negotiation and documentation of this transaction. Lisa Treannie and Shannon Zollo were attorneys for this intercompany arrangement.

Morse, Barnes-Brown Pendleton, PC, focuses exclusively on the core legal services that businesses need to succeed. The law firm assists businesses of all sizes — from start-ups to Fortune 1000 companies — in the areas of business law, technology and intellectual property, employment and immigration and taxation.

Morse, Barnes-Brown Pendleton, PC
Reservoir Place
1601 Trapelo Road, Suite 205
Waltham, MA 02451
781-622-5930
mbbp.com